Private Advisor Group LLC Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

Private Advisor Group LLC acquired a new stake in Mettler-Toledo International Inc. (NYSE:MTD) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 264 shares of the medical instruments supplier’s stock, valued at approximately $404,000.

A number of other hedge funds have also modified their holdings of MTD. Edmond DE Rothschild Holding S.A. acquired a new position in shares of Mettler-Toledo International in the fourth quarter valued at about $26,000. Ronald Blue Trust Inc. grew its holdings in Mettler-Toledo International by 72.7% during the first quarter. Ronald Blue Trust Inc. now owns 19 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 8 shares during the period. Bell Investment Advisors Inc grew its holdings in Mettler-Toledo International by 84.6% during the fourth quarter. Bell Investment Advisors Inc now owns 24 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 11 shares during the period. Compagnie Lombard Odier SCmA acquired a new stake in Mettler-Toledo International during the fourth quarter worth about $43,000. Finally, Massmutual Trust Co. FSB ADV grew its holdings in Mettler-Toledo International by 57.9% during the first quarter. Massmutual Trust Co. FSB ADV now owns 30 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 11 shares during the period. 93.11% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

MTD has been the topic of several analyst reports. StockNews.com raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Friday, August 25th. Stifel Nicolaus lowered their price target on Mettler-Toledo International from $1,700.00 to $1,650.00 in a research report on Monday, May 8th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,454.00 to $1,366.00 in a research report on Friday, July 28th. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,660.00 to $1,520.00 and set an “overweight” rating on the stock in a research report on Monday, July 31st. Finally, TheStreet downgraded Mettler-Toledo International from a “b-” rating to a “c+” rating in a research report on Tuesday, August 15th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,470.14.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,222.50 on Monday. The company has a market cap of $26.73 billion, a PE ratio of 30.73, a price-to-earnings-growth ratio of 3.06 and a beta of 1.14. The stock’s 50 day simple moving average is $1,268.43 and its 200-day simple moving average is $1,376.25. Mettler-Toledo International Inc. has a 1-year low of $1,065.55 and a 1-year high of $1,615.97. The company has a debt-to-equity ratio of 76.98, a current ratio of 1.24 and a quick ratio of 0.84.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, July 27th. The medical instruments supplier reported $10.19 earnings per share for the quarter, beating the consensus estimate of $9.99 by $0.20. The business had revenue of $982.12 million for the quarter, compared to the consensus estimate of $1 billion. Mettler-Toledo International had a negative return on equity of 2,136.23% and a net margin of 22.48%. As a group, equities research analysts anticipate that Mettler-Toledo International Inc. will post 40.63 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.